Navigation Links
Fertility Specialist Candice O’Hern Perfetto, M.D., Joins Houston’s Center of Reproductive Medicine
Date:8/7/2014

(PRWEB) August 07, 2014

Center of Reproductive Medicine (CORM), a leading infertility clinic in Texas, is excited to announce that fertility specialist Candice O’Hern Perfetto, M.D., will be joining the clinic’s experienced staff on August 11. As an American Board of Obstetrics and Gynecology certified physician, Dr. Perfetto will bring a wide range of expertise to CORM’s unique and thorough approach to infertility.

Dr. Perfetto completed her postdoctoral fellowship in reproductive endocrinology and infertility at Stanford University Medical Center in Palo Alto, CA after completing a residency at the renowned George Washington University Medical Center in Washington, DC. She began her education at the University of California, Santa Barbara, before earning her doctor of medicine degree at Georgetown University School of Medicine.

CORM’s newest physician brings with her an expertise in recurrent pregnancy loss, with past research heavily focused on that along with embryo implantation. Her research earned her recognition as the “Ernest and Amelia Gallo Post-Doctoral Fellow”, awarding her with a generous grant and the honor of being a “bass pediatric scholar” at Stanford University School of Medicine.

“We are delighted to welcome Dr. Perfetto to our CORM family. She is a great fit not only to CORM, but to the greater Houston area, where there is a high-desire for more female Reproductive Endocrinologists,” said Vicki Schnell, MD, Medical Director at CORM. “We are confident that prospective patients will be beyond satisfied with her expertise, patient care and support.”

With the addition of Dr. Perfetto, the talented team at CORM will continue to provide the highest pregnancy success rates for its patients in a positive and nurturing environment. The experts at CORM provide innovative, minimally invasive and cost-effective fertility programs that are customized the meet the individual needs of each patient.

To schedule an appointment with Dr. Perfetto or to learn more about CORM, visit infertilitytexas.com or call 713-790-9900.

About Center of Reproductive Medicine:

Established in 1993, Center of Reproductive Medicine (CORM) was founded by Vicki Schnell, M.D. and has locations in Clear Lake, Houston Medical Center, Southeast Texas and a satellite office in Pearland. CORM’s main location is a full-service, state-of-the-art facility with a surgery suite and IVF lab that allows treatment of all fertility-related diagnoses. With four fertility specialists, CORM has more than thirty years of combined experience and consistently ranks high in fertility success rates. The physicians and staff at CORM provide a positive and nurturing environment for all patients, aiming to provide the most cost-effective and minimally invasive fertility solution. For more information on CORM’s fertility services, please visit http://www.infertilitytexas.com or call 281-332-0073 to schedule an appointment or speak directly with an experienced staff member.

Read the full story at http://www.prweb.com/releases/newfertilitydoctor/inHouston/prweb12076918.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Men and women receive different fertility advice following cancer diagnosis
2. Men and Women With Cancer May Receive Different Fertility Information
3. Could Fertility Drugs Make Kids Shorter?
4. Under Right Conditions, Fertility Treatment Can Equal Natural Conception Rates: Study
5. Success of fertility treatment may approach natural birth rate
6. Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders
7. Heavy Coffee Intake May Affect Fertility Treatments: Study
8. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
9. Can Fertility Treatments Influence Later Breast Cancer Risk?
10. Fertility drug usage and cancer risk
11. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: